Trials / Active Not Recruiting
Active Not RecruitingNCT06652958
A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV
A Phase 1, Open-Label, Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VH4527079, Administered Either Intravenously or Subcutaneously to Healthy Adults and Persons With HIV
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the safety, tolerability, and pharmacokinetics (PK) of a single dose administration of VH4527079 by subcutaneous (SC) injection or by intravenous (IV) infusion in healthy adult participants and multiple dose administration by IV infusion in healthy adult participants and in Persons with HIV (PWH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | VH4527079 | VH4527079 solution for injection or infusion will be administered either by SC injection or IV infusion respectively. |
Timeline
- Start date
- 2024-10-02
- Primary completion
- 2026-09-09
- Completion
- 2026-09-09
- First posted
- 2024-10-22
- Last updated
- 2026-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06652958. Inclusion in this directory is not an endorsement.